{"id":15710,"date":"2012-11-02T02:30:00","date_gmt":"2012-11-02T01:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/imprese-dompe-farmaceutici-punta-a-russia-e-far-east-mf\/"},"modified":"2012-11-02T02:30:00","modified_gmt":"2012-11-02T01:30:00","slug":"imprese-dompe-farmaceutici-punta-a-russia-e-far-east-mf","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/imprese-dompe-farmaceutici-punta-a-russia-e-far-east-mf\/","title":{"rendered":"Companies: Dompe&#039; Farmaceutici aims at Russia and the Far East (MF)"},"content":{"rendered":"<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 0pt; background: white; tab-stops: 45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt\"><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\">MILAN (MF-DJ) \u2013 With a national market for &quot;primary care&quot; drugs that will drop by 4.5% in 2012, with a forecast of an average annual drop of 4% in the next five years, Dompe&#039; Farmaceutici is aiming at the new frontiers of biotech, namely Russia and the Far East. <\/span><span style=\"font-family: &quot;Courier New&quot;; color: black; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\"><\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 10pt; background: white; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto\"><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\">A first clue, writes MF, is the agreement signed a few days ago with the Russian Chem Rar, a company that also works for the Federal Agency for Scientific Innovation, for the establishment of a joint venture aimed at developing and marketing a drug for the treatment of diabetes. <\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 10pt; background: white; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto\"><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\">The company&#039;s goal now is to establish strategic partnerships also in Korea, China and Japan. <\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 10pt; background: white; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto\"><span lang=\"EN-US\" style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; font-size: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-ansi-language: EN-US\">red\/bc <\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 10pt; background: white; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto\"><span lang=\"EN-US\" style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; font-size: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-ansi-language: EN-US\">(END) Dow Jones Newswires<\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 10pt; background: white; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto\"><span lang=\"EN-US\" style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; font-size: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-ansi-language: EN-US\">November 02, 2012 04:11 ET (08:11 GMT)<\/p>\n<p><\/span><\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>MILANO (MF-DJ)&#8211;Con un mercato nazionale dei farmaci &quot;primary care&quot; che nel 2012 flettera&#8217; del 4,5%, con una previsione di un calo medio annuo del 4% nel prossimo quinquennio, la Dompe&#8217; Farmaceutici punta alle nuove frontiere del biotech, cioe&#8217; Russia e Far East. Un primo indizio, scrive MF, e&#8217; l&#8217;accordo siglato alcuni giorni fa con la &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-15710","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/15710","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=15710"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/15710\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=15710"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=15710"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=15710"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}